Prognostic factors in adult acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 150, Issue 4, 2010, Pages 389-405

  Rowe, Jacob M ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

acute lymphoblastic leukaemia; adults; prognostic factors

Indexed keywords

ASPARAGINASE; HLA DR ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD 19; NOTCH1 RECEPTOR; PREDNISONE; TUMOR MARKER; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE DISTRIBUTION; ALLOTRANSPLANTATION; B LYMPHOCYTE; BAALC GENE; CANCER RELAPSE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CYTOGENETICS; DISEASE FREE SURVIVAL; ELDERLY CARE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; HUMAN; IMMUNOPHENOTYPING; INTENSIVE CARE; LEUKOCYTE COUNT; ONCOGENE; PATHOGENESIS; PHARMACOGENETICS; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; PROGNOSIS; REMISSION; REVIEW; SEX DIFFERENCE; T LYMPHOCYTE; TREATMENT RESPONSE;

ADULT; AGE FACTORS; AGED; CENTRAL NERVOUS SYSTEM; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIC INFILTRATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECURRENCE; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77955157595     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08246.x     Document Type: Review

References (121)

1. d'Argouges, S., Wissing, S., Brandl, C., Prang, N., Lutterbuese, R., Kozhich, A., Suzich, J., Locher, M., Kiener, P., Kufer, P., Hofmeister, R., Baeuerle, P.A. Bargou, R.C. (2009) Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cells. Leukemia Research, 33, 465 473.
2. Asnafi, V., Buzyn, A., Le Noir, S., Baleydier, F., Simon, A., Beldjord, K., Reman, O., Witz, F., Fagot, T., Tavernier, E., Turlure, P., Leguay, T., Huguet, F., Vernant, J.P., Daniel, F., Bene, M.C., Ifrah, N., Thomas, X., Dombret, H. Macintyre, E. (2009) NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a group for research on adult acute lymphoblastic leukemia (GRAALL) study. Blood, 113, 3918 3924.
3. Bachanova, V., Verneris, M.R., DeFor, T., Brunstein, C.G. Weisdorf, D.J. (2009) Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation. Blood, 113, 2902 2905.
4. Baldus, C.D., Martus, P., Burmeister, T., Schwartz, S., Gokbuget, N., Bloomfield, C.D., Hoelzer, D., Thiel, E. Hofmann, W.K. (2007) Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome. Journal of Clinical Oncology, 25, 3739 3745.
5. Barrett, A.J., Horowitz, M.M., Ash, R.C., Atkinson, K., Gale, R.P., Goldman, J.M., Henslee-Downey, P.J., Herzig, R.H., Speck, B., Zwaan, F.E. Bortin, M.M. (1992) Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood, 79, 3067 3070.
6. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. Sultan, C. (1981) The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. British Journal Haematology, 47, 553 561.
7. Bruggemann, M., Raff, T., Flohr, T., Gokbuget, N., Nakao, M., Droese, J., Luschen, S., Pott, C., Ritgen, M., Scheuring, U., Horst, H.A., Thiel, E., Hoelzer, D., Bartram, C.R. Kneba, M. (2006) Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. Blood, 107, 1116 1123.
8. Bruggemann, M., Schrauder, A., Raff, T., Pfeifer, H., Dworzak, M., Ottmann, O.G., Asnafi, V., Baruchel, A., Bassan, R., Benoit, Y., Biondi, A., Cave, H., Dombret, H., Fielding, A.K., Foa, R., Gokbuget, N., Goldstone, A.H., Goulden, N., Henze, G., Hoelzer, D., Janka-Schaub, G.E., Macintyre, E.A., Pieters, R., Rambaldi, A., Ribera, J.M., Schmiegelow, K., Spinelli, O., Stary, J., von Stackelberg, A., Kneba, M., Schrappe, M. van Dongen, J.J. (2010) Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia, 24, 521 535.
9. Burmeister, T., Gokbuget, N., Schwartz, S., Fischer, L., Hubert, D., Sindram, A., Hoelzer, D. Thiel, E. (2010) Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia. Haematologica, 95, 241 246.
10. Campana, D. (2009) Minimal residual disease in acute lymphoblastic leukemia. Seminars in Hematology, 46, 100 106.
11. Cave, H., van der Werff ten Bosch, J., Suciu, S., Guidal, C., Waterkeyn, C., Otten, J., Bakkus, M., Thielemans, K., Grandchamp, B. Vilmer, E. (1998) Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer-Childhood Leukemia Cooperative Group. New England Journal of Medicine, 339, 591 598.
12. Chao, N.J., Blume, K.G., Forman, S.J. Snyder, D.S. (1995) Long-term follow-up of allogeneic bone marrow recipients for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood, 85, 3353 3354.
13. Chen, Z.S., Lee, K., Walther, S., Raftogianis, R.B., Kuwano, M., Zeng, H. Kruh, G.D. (2002) Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Research, 62, 3144 3150.
14. Chessells, J.M., Richards, S.M., Bailey, C.C., Lilleyman, J.S. Eden, O.B. (1995) Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials. British Journal of Haematology, 89, 364 372.
15. Conter, V., Bartram, C.R., Valsecchi, M.G., Schrauder, A., Panzer-Grumayer, R., Moricke, A., Arico, M., Zimmermann, M., Mann, G., De Rossi, G., Stanulla, M., Locatelli, F., Basso, G., Niggli, F., Barisone, E., Henze, G., Ludwig, W.D., Haas, O.A., Cazzaniga, G., Koehler, R., Silvestri, D., Bradtke, J., Parasole, R., Beier, R., van Dongen, J.J., Biondi, A. Schrappe, M. (2010) Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood, 115, 3206 3214.
16. Copelan, E.A. McGuire, E.A. (1995) The biology and treatment of acute lymphoblastic leukemia in adults. Blood, 85, 1151 1168.
17. Coustan-Smith, E., Behm, F.G., Sanchez, J., Boyett, J.M., Hancock, M.L., Raimondi, S.C., Rubnitz, J.E., Rivera, G.K., Sandlund, J.T., Pui, C.H. Campana, D. (1998) Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet, 351, 550 554.
18. Czuczman, M.S., Dodge, R.K., Stewart, C.C., Frankel, S.R., Davey, F.R., Powell, B.L., Szatrowski, T.P., Schiffer, C.A., Larson, R.A. Bloomfield, C.D. (1999) Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364. Blood, 93, 3931 3939.
19. DeAngelo, D.J. (2009) Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma. Hematology/oncology Clinics of North America, 23, 1121 1135. vii-viii.
20. Dombret, H., Gabert, J., Boiron, J.M., Rigal-Huguet, F., Blaise, D., Thomas, X., Delannoy, A., Buzyn, A., Bilhou-Nabera, C., Cayuela, J.M., Fenaux, P., Bourhis, J.H., Fegueux, N., Charrin, C., Boucheix, C., Lheritier, V., Esperou, H., MacIntyre, E., Vernant, J.P. Fiere, D. (2002) Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia - results of the prospective multicenter LALA-94 trial. Blood, 100, 2357 2366.
21. van Dongen, J.J., Seriu, T., Panzer-Grumayer, E.R., Biondi, A., Pongers-Willemse, M.J., Corral, L., Stolz, F., Schrappe, M., Masera, G., Kamps, W.A., Gadner, H., van Wering, E.R., Ludwig, W.D., Basso, G., de Bruijn, M.A., Cazzaniga, G., Hettinger, K., van der Does-van den Berg, A., Hop, W.C., Riehm, H. Bartram, C.R. (1998) Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet, 352, 1731 1738. (Pubitemid 28534955)
22. van Es, J.H., van Gijn, M.E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., Cozijnsen, M., Robine, S., Winton, D.J., Radtke, F. Clevers, H. (2005) Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature, 435, 959 963.
23. Evans, W.E. McLeod, H.L. (2003) Pharmacogenomics-drug disposition, drug targets, and side effects. New England Journal of Medicine, 348, 538 549.
24. Evans, W.E. Relling, M.V. (2004) Moving towards individualized medicine with pharmacogenomics. Nature, 429, 464 468.
25. Faderl, S., Kantarjian, H.M., Talpaz, M. Estrov, Z. (1998) Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood, 91, 3995 4019. (Pubitemid 28261960)
26. Faderl, S., Jeha, S. Kantarjian, H.M. (2003) The biology and therapy of adult acute lymphoblastic leukemia. Cancer, 98, 1337 1354.
27. Ferrando, A.A. (2009) The role of NOTCH1 signaling in T-ALL. Hematology American Society of Hematology. Education Program, 2009, 353 361.
28. Fielding, A.K. (2010) Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica, 95, 8 12.
29. Fielding, A.K. Goldstone, A.H. (2008) Allogeneic haematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemia. Bone Marrow Transplantation, 41, 447 453.
30. Fielding, A.K., Richards, S.M., Chopra, R., Lazarus, H.M., Litzow, M.R., Buck, G., Durrant, I.J., Luger, S.M., Marks, D.I., Franklin, I.M., McMillan, A.K., Tallman, M.S., Rowe, J.M. Goldstone, A.H. (2007) Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood, 109, 944 950.
31. Fielding, A.K., Rowe, J.M., Richards, S.M., Buck, G., Moorman, A.V., Durrant, I.J., Marks, D.I., McMillan, A.K., Litzow, M.R., Lazarus, H.M., Foroni, L., Dewald, G., Franklin, I.M., Luger, S.M., Paietta, E., Wiernik, P.H., Tallman, M.S. Goldstone, A.H. (2009) Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993. Blood, 113, 4489 4496.
32. Fine, B.M., Kaspers, G.J., Ho, M., Loonen, A.H. Boxer, L.M. (2005) A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia. Cancer Research, 65, 291 299.
33. Foa, R., Vitale, A., Mancini, M., Cuneo, A., Mecucci, C., Elia, L., Lombardo, R., Saglio, G., Torelli, G., Annino, L., Specchia, G., Damasio, E., Recchia, A., Di Raimondo, F., Morra, E., Volpe, E., Tafuri, A., Fazi, P., Hunger, S.P. Mandelli, F. (2003) E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features. British Journal Haematology, 120, 484 487.
34. Garg, R., Kantarjian, H., Thomas, D., Faderl, S., Ravandi, F., Lovshe, D., Pierce, S. O'Brien, S. (2009) Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapy. Cancer, 115, 2147 2154.
35. Gokbuget, N. Hoelzer, D. (2009) Treatment of adult acute lymphoblastic leukemia. Seminars in Hematology, 46, 64 75.
36. Gokbuget, N., de Witt, M., Gerhardt, A., Lipp, Th., Rieder, H., Schwarts, S., Sommer, S., Voliotis, D., Thiel, E. Hoelzer, D. (2000a) Results of a shortened, dose-reduced treatment protocol in elderly patients with acute lymphoblastic leukemia. Blood, 96, 718a.
37. Gokbuget, N., Hoelzer, D., Arnold, R., Bohme, A., Bartram, C.R., Freund, M., Ganser, A., Kneba, M., Langer, W., Lipp, T., Ludwig, W.D., Maschmeyer, G., Rieder, H., Thiel, E., Weiss, A. Messerer, D. (2000b) Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL). Hematology/oncology Clinics of North America, 14, 1307 1325. ix.
38. Goldstone, A.H., Richards, S.M., Lazarus, H.M., Tallman, M.S., Buck, G., Fielding, A.K., Burnett, A.K., Chopra, R., Wiernik, P.H., Foroni, L., Paietta, E., Litzow, M.R., Marks, D.I., Durrant, J., McMillan, A., Franklin, I.M., Luger, S., Ciobanu, N. Rowe, J.M. (2008) In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood, 111, 1827 1833.
39. Grabher, C., von Boehmer, H. Look, A.T. (2006) Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nature Reviews. Cancer, 6, 347 359.
40. Griffin, T.C., Weitzman, S., Weinstein, H., Chang, M., Cairo, M., Hutchison, R., Shiramizu, B., Wiley, J., Woods, D., Barnich, M. Gross, T.G. (2009) A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Pediatric Blood & Cancer, 52, 177 181.
41. Groupe Francais de Cytogenetique Hematologique (1996) Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A Collaborative Study of the Groupe Francais de Cytogenetique Hematologique. Blood, 87, 3135 3142.
42. Hayhoe, F.G. (1984) Cytochemistry of the acute leukaemias. Histochemical Journal, 16, 1051 1059.
43. Heerema, N.A., Sather, H.N., Sensel, M.G., Liu-Mares, W., Lange, B.J., Bostrom, B.C., Nachman, J.B., Steinherz, P.G., Hutchinson, R., Gaynon, P.S., Arthur, D.C. Uckun, F.M. (1999) Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood, 94, 1537 1544.
44. Hoelzer, D. (1996) Diagnosis and treatment of adult acute lymphoblastic leukemia. In : Neoplastic disease of the blood (ed. by P.H. Wiernik, G. Canellos, J. Dutcher R.A. Kyle pp. 295 316. Churchill. Livingston, New York, NY.
45. Hoelzer, D., Thiel, E., Loffler, H., Bodenstein, H., Plaumann, L., Buchner, T., Urbanitz, D., Koch, P., Heimpel, H., Engelhardt Muller, R.U., Wendt, F.-C., Sodomann, H., Rühl, H., Herrmann, F., Kaboth, W., Dietzfelbinger, H., Pralle, H., Lunscken, Ch., Hellriegel, K.-P., Spors, S., Nowrousian, R.M., Fischer, J., Fülle, H., Mitrou, P.S., Pfreundschuh, M., Görg, Ch., Emmerich, B., Queisser, W., Meyer, P., Labedzki, L., Essers, U., König, H., Mainzer, K., Herrmann, R., Messerer, D. Zwingers, T. (1984) Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood, 64, 38 47.
46. Hoelzer, D., Thiel, E., Loffler, H., Buchner, T., Ganser, A., Heil, G., Koch, P., Freund, M., Diedrich, H., Ruhl, H., Maschmeyer, G., Lipp, T., Nowrousian, M.R., Burkert, M., Gerecke, D., Pralle, H., Muller, U., Lunscken, Ch., Fulle, H., Ho, A.D., Kuchler, R., Busch, F.W., Schneider, W., Gorg, Ch., Emmerich, B., Braumann, D., Vaupel, H.A., von Paleske, A., Bartels, H., Neiss, A. Messerer, D. (1988) Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood, 71, 123 131.
47. Hoelzer, D., Ludwig, W.D., Thiel, E., Gassmann, W., Loffler, H., Fonatsch, C., Rieder, H., Heil, G., Heinze, B., Arnold, R., Hossfeld, D., Buchner, T., Koch, P., Freund, M., Hiddemann, W., Maschmeyer, G., Heyll, A., Aul, C., Faak, T., Kuse, R., Ittel, T.H., Gramatzki, M., Diedrich, H., Kolbe, K., Fuhr, H.G., Fischer, K., Schadeck-Gressel, C., Weiss, A., Strohscheer, I., Metzner, B., Fabry, U., Gokbuget, N., Volkers, B., Messerer, D. Uberla, K. (1996) Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood, 87, 495 508.
48. Hoelzer, D., Gokbuget, N., Beck, J., Burmeister, T., Giagounidis, A., Glasmacher, A., Pfeifer, H., Rieder, H., Schmid, M., Thiel, E., Wassmann, B. Ottmann, O. (2004) Subtype adjusted therapy improves outcome of elderly patients with acute lymphoblastic leukemia. Blood, 104, 747a.
49. Holleman, A., Cheok, M.H., den Boer, M.L., Yang, W., Veerman, A.J., Kazemier, K.M., Pei, D., Cheng, C., Pui, C.H., Relling, M.V., Janka-Schaub, G.E., Pieters, R. Evans, W.E. (2004) Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. New England Journal of Medicine, 351, 533 542.
50. Holowiecki, J., Krawczyk-Kulis, M., Giebel, S., Jagoda, K., Stella-Holowiecka, B., Piatkowska-Jakubas, B., Paluszewska, M., Seferynska, I., Lewandowski, K., Kielbinski, M., Czyz, A., Balana-Nowak, A., Krol, M., Skotnicki, A.B., Jedrzejczak, W.W., Warzocha, K., Lange, A. Hellmann, A. (2008) Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4-2002 MRD Study. British Journal of Haematology, 142, 227 237.
51. Hulot, J.S., Villard, E., Maguy, A., Morel, V., Mir, L., Tostivint, I., William-Faltaos, D., Fernandez, C., Hatem, S., Deray, G., Komajda, M., Leblond, V. Lechat, P. (2005) A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination. Pharmacogenetics and Genomics, 15, 277 285.
52. Hunault, M., Harousseau, J.L., Delain, M., Truchan-Graczyk, M., Cahn, J.Y., Witz, F., Lamy, T., Pignon, B., Jouet, J.P., Garidi, R., Caillot, D., Berthou, C., Guyotat, D., Sadoun, A., Sotto, J.J., Lioure, B., Casassus, P., Solal-Celigny, P., Stalnikiewicz, L., Audhuy, B., Blanchet, O., Baranger, L., Bene, M.C. Ifrah, N. (2004) Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial. Blood, 104, 3028 3037.
53. Issa, J.P. (2007) DNA methylation as a therapeutic target in cancer. Clinical Cancer Research, 13, 1634 1637.
54. Jaime-Perez, J.C., Rodriguez-Romo, L.N., Gonzalez-Llano, O., Chapa-Rodriguez, A. Gomez-Almaguer, D. (2009) Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy. British Journal Haematology, 144, 794 795.
55. Keleti, J., Revesz, T. Schuler, D. (1978) Morphological diagnosis in childhood leukaemia. British Journal Haematology, 40, 501 502.
56. Khalidi, H.S., O'Donnell, M.R., Slovak, M.L. Arber, D.A. (1999) Adult precursor-B acute lymphoblastic leukemia with translocations involving chromosome band 19p13 is associated with poor prognosis. Cancer Genetics and Cytogenetics, 109, 58 65.
57. Kühnl, A., Göekbuget, N., Stroux, A., Burmeister, T., Neumann, M., Heesch, S., Haferlach, T., Hoelzer, D., Hofmann, W.K., Thiel, E. Baldus, C.D. (2010) High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemia. Blood, 115, 3737 3744.
58. Lang, P., Barbin, K., Feuchtinger, T., Greil, J., Peipp, M., Zunino, S.J., Pfeiffer, M., Handgretinger, R., Niethammer, D. Fey, G.H. (2004) Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts. Blood, 103, 3982 3985.
59. Larson, R.A. (2005) Acute lymphoblastic leukemia: older patients and newer drugs. Hematology American Society of Hematology. Education Program, 2005, 131 136.
60. Larson, R.A. (2007) Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine. Seminars in Oncology, 34, S13 S20.
61. Laughton, S.J., Ashton, L.J., Kwan, E., Norris, M.D., Haber, M. Marshall, G.M. (2005) Early responses to chemotherapy of normal and malignant hematologic cells are prognostic in children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 23, 2264 2271.
62. Lazarus, H.M., Richards, S.M., Chopra, R., Litzow, M.R., Burnett, A.K., Wiernik, P.H., Franklin, I.M., Tallman, M.S., Cook, L., Buck, G., Durrant, I.J., Rowe, J.M. Goldstone, A.H. (2006) Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993. Blood, 108, 465 472.
63. Lazzarino, M., Morra, E., Alessandrino, E.P., Canevari, A., Salvaneschi, L., Castelli, G., Brusamolino, E., Pagnucco, G., Isernia, P., Orlandi, E., Zei, G. Bernasconi, C. (1982) Adult acute lymphoblastic leukemia. Response to therapy according to presenting features in 62 patients. European Journal of Cancer & Clinical Oncology, 18, 813 819.
64. Leclerc, G.J., Mou, C., Leclerc, G.M., Mian, A.M. Barredo, J.C. (2010) Histone deacetylase inhibitors induce FPGS mRNA expression and intracellular accumulation of long-chain methotrexate polyglutamates in childhood acute lymphoblastic leukemia: implications for combination therapy. Leukemia, 24, 552 562.
65. Lewis, H.D., Leveridge, M., Strack, P.R., Haldon, C.D., O'Neil, J., Kim, H., Madin, A., Hannam, J.C., Look, A.T., Kohl, N., Draetta, G., Harrison, T., Kerby, J.A., Shearman, M.S. Beher, D. (2007) Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling. Chemistry & Biology, 14, 209 219.
66. Litzow, M.R. (2009) Evolving paradigms in the therapy of Philadelphia-chromosome-negative acute lymphoblastic leukemia in adults. Hematology American Society of Hematology. Education Program, 2009, 362 370.
67. Mancini, M., Scappaticci, D., Cimino, G., Nanni, M., Derme, V., Elia, L., Tafuri, A., Vignetti, M., Vitale, A., Cuneo, A., Castoldi, G., Saglio, G., Pane, F., Mecucci, C., Camera, A., Specchia, G., Tedeschi, A., Di Raimondo, F., Fioritoni, G., Fabbiano, F., Marmont, F., Ferrara, F., Cascavilla, N., Todeschini, G., Nobile, F., Kropp, M.G., Leoni, P., Tabilio, A., Luppi, M., Annino, L., Mandelli, F. Foa, R. (2005) A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol. Blood, 105, 3434 3441.
68. Mansour, M.R., Linch, D.C., Foroni, L., Goldstone, A.H. Gale, R.E. (2006) High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia. Leukemia, 20, 537 539.
69. Mansour, M.R., Sulis, M.L., Duke, V., Foroni, L., Jenkinson, S., Koo, K., Allen, C.G., Gale, R.E., Buck, G., Richards, S., Paietta, E., Rowe, J.M., Tallman, M.S., Goldstone, A.H., Ferrando, A.A. Linch, D.C. (2009) Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol. Journal of Clinical Oncology, 27, 4352 4356.
70. Marks, D.I., Perez, W.S., He, W., Zhang, M.J., Bishop, M.R., Bolwell, B.J., Bredeson, C.N., Copelan, E.A., Gale, R.P., Gupta, V., Hale, G.A., Isola, L.M., Jakubowski, A.A., Keating, A., Klumpp, T.R., Lazarus, H.M., Liesveld, J.L., Maziarz, R.T., McCarthy, P.L., Sabloff, M., Schiller, G., Sierra, J., Tallman, M.S., Waller, E.K., Wiernik, P.H. Weisdorf, D.J. (2008) Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. Blood, 112, 426 434.
71. Marks, D.I., Wang, T., Peréz, W.S., Bunjes, D.W., DiPersio, J.F., Tallman, M.S. Weisdorf, D.J. (2009) Comparison of outcomes for non-myeloablative (NMA) and myeloablative (MA) conditioning for adults with acute lymphoblastic leukaemia (ALL) in first and second complete remission (CR): a center for international blood and marrow transplant research (CIBMTR) analysis. Blood, 114, 872a.
72. Maury, S., Huguet, F., Leguay, T., Lacombe, F., Maynadie, M., Girard, S., de Labarthe, A., Kuhlein, E., Raffoux, E., Thomas, X., Chevallier, P., Buzyn, A., Delannoy, A., Chalandon, Y., Vernant, J.P., Rousselot, P., Macintyre, E., Ifrah, N., Dombret, H. Bene, M.C. (2010) Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia. Haematologica, 95, 324 328.
73. Milani, L., Lundmark, A., Kiialainen, A., Nordlund, J., Flaegstad, T., Forestier, E., Heyman, M., Jonmundsson, G., Kanerva, J., Schmiegelow, K., Soderhall, S., Gustafsson, M.G., Lonnerholm, G. Syvanen, A.C. (2010) DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia. Blood, 115, 1214 1225.
74. Mohty, M., Labopin, M., Tabrizzi, R., Theorin, N., Fauser, A.A., Rambaldi, A., Maertens, J., Slavin, S., Majolino, I., Nagler, A., Blaise, D. Rocha, V. (2008) Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation. Haematologica, 93, 303 306.
75. Moorman, A.V., Harrison, C.J., Buck, G.A., Richards, S.M., Secker-Walker, L.M., Martineau, M., Vance, G.H., Cherry, A.M., Higgins, R.R., Fielding, A.K., Foroni, L., Paietta, E., Tallman, M.S., Litzow, M.R., Wiernik, P.H., Rowe, J.M., Goldstone, A.H. Dewald, G.W. (2007) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood, 109, 3189 3197.
76. Moorman, A.V., Chilton, L., Wilkinson, J., Ensor, H.M., Bown, N. Proctor, S.J. (2010) A population-based cytogenetic study of adults with acute lymphoblastic leukemia. Blood, 115, 206 214.
77. Mortuza, F.Y., Papaioannou, M., Moreira, I.M., Coyle, L.A., Gameiro, P., Gandini, D., Prentice, H.G., Goldstone, A., Hoffbrand, A.V. Foroni, L. (2002) Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia. Journal of Clinical Oncology, 20, 1094 1104.
78. Mullighan, C.G., Su, X., Zhang, J., Radtke, I., Phillips, L.A., Miller, C.B., Ma, J., Liu, W., Cheng, C., Schulman, B.A., Harvey, R.C., Chen, I.M., Clifford, R.J., Carroll, W.L., Reaman, G., Bowman, W.P., Devidas, M., Gerhard, D.S., Yang, W., Relling, M.V., Shurtleff, S.A., Campana, D., Borowitz, M.J., Pui, C.H., Smith, M., Hunger, S.P., Willman, C.L. Downing, J.R. (2009) Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. New England Journal of Medicine, 360, 470 480.
79. Oriol, A., Vives, S., Hernandez-Rivas, J.M., Tormo, M., Heras, I., Rivas, C., Bethencourt, C., Moscardo, F., Bueno, J., Grande, C., del Potro, E., Guardia, R., Brunet, S., Bergua, J., Bernal, T., Moreno, M.J., Calvo, C., Bastida, P., Feliu, E. Ribera, J.M. (2010) Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group. Haematologica, 95, 589 596.
80. Ottmann, O.G. Pfeifer, H. (2009) Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Hematology American Society of Hematology. Education Program, 2009, 371 381.
81. Pagano, L., Mele, L., Trape, G. Leone, G. (2004) The treatment of acute lymphoblastic leukaemia in the elderly. Leukaemia & Lymphoma, 45, 117 123.
82. Pantazopoulos, N. Sinks, L.F. (1974) Morphological criteria for prognostication of acute lymphoblastic leukaemia. British Journal of Haematology, 27, 25 30.
83. Patel, B., Rai, L., Buck, G., Richards, S.M., Mortuza, Y., Mitchell, W., Gerrard, G., Moorman, A.V., Duke, V., Hoffbrand, A.V., Fielding, A.K., Goldstone, A.H. Foroni, L. (2010) Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993. British Journal of Haematology, 148, 80 89.
84. Petersdorf, S.H., Kopecky, K.J., Head, D.R., Boldt, D.H., Balcerzak, S.P., Wun, T., Roy, V., Veith, R.W. Appelbaum, F.R. (2001) Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest oncology group study. Leukemia, 15, 208 216.
85. Piccaluga, P.P., Malagola, M., Rondoni, M., Ottaviani, E., Testoni, N., Laterza, C., Visani, G., Pileri, S.A., Martinelli, G. Baccarani, M. (2006) Poor outcome of adult acute lymphoblastic leukemia patients carrying the (1;19)(q23;p13) translocation. Leukaemia & Lymphoma, 47, 469 472.
86. Pui, C.H. Evans, W.E. (2006) Treatment of acute lymphoblastic leukemia. New England Journal of Medicine, 354, 166 178.
87. Pui, C.H., Rubnitz, J.E., Hancock, M.L., Downing, J.R., Raimondi, S.C., Rivera, G.K., Sandlund, J.T., Ribeiro, R.C., Head, D.R., Relling, M.V., Evans, W.E. Behm, F.G. (1998) Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 16, 3768 3773.
88. Pui, C.H., Boyett, J.M., Relling, M.V., Harrison, P.L., Rivera, G.K., Behm, F.G., Sandlund, J.T., Ribeiro, R.C., Rubnitz, J.E., Gajjar, A. Evans, W.E. (1999) Sex differences in prognosis for children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 17, 818 824.
89. Pui, C.H., Sallan, S., Relling, M.V., Masera, G. Evans, W.E. (2001a) International Childhood Acute Lymphoblastic Leukemia Workshop: Sausalito, CA, 30 November-1 December 2000. Leukemia, 15, 707 715.
90. Pui, C.H., Campana, D. Evans, W.E. (2001b) Childhood acute lymphoblastic leukaemia - current status and future perspectives. The Lancet Oncology, 2, 597 607.
91. Pui, C.H., Relling, M.V. Downing, J.R. (2004) Acute lymphoblastic leukemia. New England Journal of Medicine, 350, 1535 1548.
92. Pui, C.H., Robison, L.L. Look, A.T. (2008) Acute lymphoblastic leukaemia. Lancet, 371, 1030 1043.
93. Raetz, E.A., Cairo, M.S., Borowitz, M.J., Blaney, S.M., Krailo, M.D., Leil, T.A., Reid, J.M., Goldenberg, D.M., Wegener, W.A., Carroll, W.L. Adamson, P.C. (2008) Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a children's oncology group pilot study. Journal of Clinical Oncology, 26, 3756 3762.
94. Raff, T., Gokbuget, N., Luschen, S., Reutzel, R., Ritgen, M., Irmer, S., Bottcher, S., Horst, H.A., Kneba, M., Hoelzer, D. Bruggemann, M. (2007) Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials. Blood, 109, 910 915.
95. Rau, T., Erney, B., Gores, R., Eschenhagen, T., Beck, J. Langer, T. (2006) High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations. Clinical Pharmacology and Therapeutics, 80, 468 476.
96. Real, P.J. Ferrando, A.A. (2009) NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia. Leukemia, 23, 1374 1377.
97. Roman-Gomez, J., Agirre, X., Jimenez-Velasco, A., Arqueros, V., Vilas-Zornoza, A., Rodriguez-Otero, P., Martin-Subero, I., Garate, L., Cordeu, L., San Jose-Eneriz, E., Martin, V., Castillejo, J.A., Bandres, E., Calasanz, M.J., Siebert, R., Heiniger, A., Torres, A. Prosper, F. (2009) Epigenetic regulation of microRNAs in acute lymphoblastic leukemia. Journal of Clinical Oncology, 27, 1316 1322.
98. Rowe, J.M. (2010) Getting to the root of (It) All, Blood, 115, 3649 3650.
99. Rowe, J.M. Goldstone, A.H. (2007) How I treat acute lymphocytic leukemia in adults. Blood, 110, 2268 2275.
100. Rowe, J.M., Buck, G., Burnett, A.K., Chopra, R., Wiernik, P.H., Richards, S.M., Lazarus, H.M., Franklin, I.M., Litzow, M.R., Ciobanu, N., Prentice, H.G., Durrant, J., Tallman, M.S. Goldstone, A.H. (2005) Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood, 106, 3760 3767.
101. Rubnitz, J.E., Wichlan, D., Devidas, M., Shuster, J., Linda, S.B., Kurtzberg, J., Bell, B., Hunger, S.P., Chauvenet, A., Pui, C.H., Camitta, B. Pullen, J. (2008) Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a children's oncology group study. Journal of Clinical Oncology, 26, 2186 2191.
102. Sanda, T., Li, X., Gutierrez, A., Ahn, Y., Neuberg, D.S., O'Neil, J., Strack, P.R., Winter, C.G., Winter, S.S., Larson, R.S., von Boehmer, H. Look, A.T. (2010) Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia. Blood, 115, 1735 1745.
103. Schnapp, L.M. (2009) Another Notch on the belt. Blood, 113, 1615 1616.
104. Schultz, K.R., Pullen, D.J., Sather, H.N., Shuster, J.J., Devidas, M., Borowitz, M.J., Carroll, A.J., Heerema, N.A., Rubnitz, J.E., Loh, M.L., Raetz, E.A., Winick, N.J., Hunger, S.P., Carroll, W.L., Gaynon, P.S. Camitta, B.M. (2007) Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood, 109, 926 935.
105. Secker-Walker, L.M., Prentice, H.G., Durrant, J., Richards, S., Hall, E. Harrison, G. (1997) Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party. British Journal Haematology, 96, 601 610.
106. Shuster, J.J., Wacker, P., Pullen, J., Humbert, J., Land, V.J., Mahoney, D.H., Jr., Lauer, S., Look, A.T., Borowitz, M.J., Carroll, A.J. Camitta, B. (1998) Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a pediatric oncology group study. Journal of Clinical Oncology, 16, 2854 2863.
107. Stanciu-Herrera, C., Morgan, C. Herrera, L. (2008) Anti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines. Leukemia Research, 32, 625 632.
108. Stanulla, M. Schrappe, M. (2009) Treatment of childhood acute lymphoblastic leukemia. Seminars in Hematology, 46, 52 63.
109. Tammam, J., Ware, C., Efferson, C., O'Neil, J., Rao, S., Qu, X., Gorenstein, J., Angagaw, M., Kim, H., Kenific, C., Kunii, K., Leach, K.J., Nikov, G., Zhao, J., Dai, X., Hardwick, J., Scott, M., Winter, C., Bristow, L., Elbi, C., Reilly, J.F., Look, T., Draetta, G., Van der Ploeg, L., Kohl, N.E., Strack, P.R. Majumder, P.K. (2009) Down-regulation of the Notch pathway mediated by a gamma-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemia. British Journal of Pharmacology, 158, 1183 1195.
110. Thomas, X., Thiebaut, A., Olteanu, N., Danaila, C., Charrin, C., Archimbaud, E. Fiere, D. (1998) Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome. Hematology and Cell Therapy, 40, 119 128.
111. Thomas, X., Olteanu, N., Charrin, C., Lheritier, V., Magaud, J.P. Fiere, D. (2001) Acute lymphoblastic leukemia in the elderly: the edouard herriot hospital experience. American Journal of Hematology, 67, 73 83.
112. Thomas, X., Boiron, J.M., Huguet, F., Dombret, H., Bradstock, K., Vey, N., Kovacsovics, T., Delannoy, A., Fegueux, N., Fenaux, P., Stamatoullas, A., Vernant, J.P., Tournilhac, O., Buzyn, A., Reman, O., Charrin, C., Boucheix, C., Gabert, J., Lheritier, V. Fiere, D. (2004) Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. Journal of Clinical Oncology, 22, 4075 4086. (Pubitemid 41185176)
113. Thomas, D.A., Faderl, S., O'Brien, S., Bueso-Ramos, C., Cortes, J., Garcia-Manero, G., Giles, F.J., Verstovsek, S., Wierda, W.G., Pierce, S.A., Shan, J., Brandt, M., Hagemeister, F.B., Keating, M.J., Cabanillas, F. Kantarjian, H. (2006) Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer, 106, 1569 1580.
114. Thomas, D.A., O'Brien, S., Jorgensen, J.L., Cortes, J., Faderl, S., Garcia-Manero, G., Verstovsek, S., Koller, C., Pierce, S., Huh, Y., Wierda, W., Keating, M.J. Kantarjian, H.M. (2009a) Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia. Blood, 113, 6330 6337.
115. Thomas, D.A., O'Brien, S. Kantarjian, H.M. (2009b) Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemia. Hematology/oncology Clinics of North America, 23, 949 971. v.
116. Vey, N., Thomas, X., Picard, C., Kovascovicz, T., Charin, C., Cayuela, J.M., Dombret, H., Dastugue, N., Huguet, F., Bastard, C., Stamatoulas, A., Giollant, M., Tournilhac, O., Macintyre, E., Buzyn, A., Bories, D., Kuentz, M., Dreyfus, F., Delannoy, A., Raynaud, S., Gratecos, N., Bordessoule, D., de Botton, S., Preudhomme, C., Reman, O., Troussard, X., Pigneux, A., Bilhou, C., Vernant, J.P., Boucheix, C. Gabert, J. (2006) Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study. Leukemia, 20, 2155 2161.
117. Viana, M.B., Maurer, H.S. Ferenc, C. (1980) Subclassification of acute lymphoblastic leukaemia in children: analysis of the reproducibility of morphological criteria and prognostic implications. British Journal of Haematology, 44, 383 388.
118. Vitale, A., Guarini, A., Ariola, C., Mancini, M., Mecucci, C., Cuneo, A., Pane, F., Saglio, G., Cimino, G., Tafuri, A., Meloni, G., Fabbiano, F., Recchia, A., Kropp, M.G., Krampera, M., Cascavilla, N., Ferrara, F., Romano, A., Mazza, P., Fozza, C., Paoloni, F., Vignetti, M. Foa, R. (2006) Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol. Blood, 107, 473 479.
119. Weng, A.P., Ferrando, A.A., Lee, W., Morris, J.P.t., Silverman, L.B., Sanchez-Irizarry, C., Blacklow, S.C., Look, A.T. Aster, J.C. (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science, 306, 269 271.
120. Wetzler, M., Dodge, R.K., Mrozek, K., Carroll, A.J., Tantravahi, R., Block, A.W., Pettenati, M.J., Le Beau, M.M., Frankel, S.R., Stewart, C.C., Szatrowski, T.P., Schiffer, C.A., Larson, R.A. Bloomfield, C.D. (1999) Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. Blood, 93, 3983 3993.
121. Wilson, K., Case, M., Minto, L., Bailey, S., Bown, N., Jesson, J., Lawson, S., Vormoor, J. Irving, J. (2010) Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34 + CD38lowCD19 + in B-lineage childhood acute lymphoblastic leukemia. Haematologica, 95, 679 683.